From: Serum neurofilament light chain level as a predictor of cognitive stage transition
MCI (n = 53) | CU (n = 146) | Total (n = 199) | |
---|---|---|---|
Serum NFL | |||
Lowest tertile | 1.00 [ref] | 1.00 [ref] | 1.00 [ref] |
Middle tertile | 9.265 (1.136-75.587)* | 4.968 (0.580-42.529) | 6.171 (1.379–27.609)* |
Highest tertile | 19.569 (2.133-128.682)** | 9.660 (1.224-76.272)* | 11.385 (2.664–48.648)** |
Age | 1.118 (1.043-1.199)** | 1.081 (1.013-1.154)* | 1.119 (1.070–1.171)** |
Sex | 0.911 (0.364-2.280) | 1.927 (0.698-5.316) | 1.599 (0.822–3.111) |
Lives alone | 1.612 (0.529-4.908) | 1.530 (0.432-5.425) | 1.522 (0.662-3.498) |
BMI | 0.863 (0.711-1.047) | 1.022 (0.866-1.206) | 0.942 (0.831–1.068) |
Education | 1.016 (0.903-1.143) | 0.927 (0.842-1.022) | 0.951 (0.888–1.018) |
Baseline MMSE score | 0.818 (0.730-0.916)** | 0.805 (0.702-0.923)** | 0.788 (0.729–0.852)** |
Initial GDS score | 1.019 (0.949-1.094) | 1.068 (0.997-1.144) | 1.054 (1.004-1.106)* |
Hypertension | 1.219 (0.494-3.008) | 1.007 (0.365-2.778) | 1.202 (0.619-2.333) |
Diabetes mellitus | 1.031 (0.341-3.112) | 4.099 (1.457-11.533) | 2.073 (0.987-4.354) |
Dyslipidemia | 0.246 (0.057-1.071) | 0.857 (0.305-2.408) | 0.429 (0.195-0.944)* |
Pill intake of more than three | 0.968 (0.392-2.386) | 0.662 (0.240-1.828) | 0.718 (0.366-1.408) |
Hippocampal volume, per 1 cm3 | 0.628 (0.447-0.882)** | 0.666 (0.448-0.989)* | 0.600 (0.477–0.756)** |
Cortical thickness, per 1 mm | 4.090 (0.226-73.875) | 0.059 (0.002-1.574) | 0.325 (0.032–3.288) |
Aβ positivity | 5.436 (1.553 – 19.030)** | 10.724 (3.584-32.091)** | 10.306 (4.594–23.124)** |
APOE ε4 carrier | 2.546 (0.981-6.661) | 1.932 (0.660-5.653) | 2.137 (1.057–4.3192)* |
Family history of dementia | 1.343 (0.526-3.430) | 2.085 (0.742-5.858) | 1.826 (0.914-3.648) |